180 related articles for article (PubMed ID: 20191583)
1. Cancer preceding giant cell arteritis: a case-control study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
[TBL] [Abstract][Full Text] [Related]
2. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
[TBL] [Abstract][Full Text] [Related]
3. Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.
Schäfer VS; Kermani TA; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Rheumatology (Oxford); 2010 Nov; 49(11):2104-8. PubMed ID: 20627970
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
5. The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study.
Dar L; Ben-Shabat N; Tiosano S; Watad A; McGonagle D; Komaneshter D; Cohen A; Bragazzi NL; Amital H
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300046
[TBL] [Abstract][Full Text] [Related]
6. Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study.
Elfishawi M; Rakholiya J; Gunderson TM; Achenbach SJ; Crowson CS; Matteson EL; Turesson C; Wadström K; Weyand C; Koster MJ; Warrington KJ
J Rheumatol; 2023 Apr; 50(4):526-531. PubMed ID: 36521923
[TBL] [Abstract][Full Text] [Related]
7. Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
J Rheumatol; 2020 May; 47(5):722-729. PubMed ID: 31308209
[TBL] [Abstract][Full Text] [Related]
8. Apolipoproteins and the risk of giant cell arteritis-a nested case-control study.
Wadström K; Jacobsson LTH; Mohammad AJ; Warrington KJ; Matteson EL; Turesson C
Arthritis Res Ther; 2024 Jan; 26(1):37. PubMed ID: 38281009
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study.
Turkiewicz A; Stamatis P; Mohammad AJ
RMD Open; 2020 Aug; 6(2):. PubMed ID: 32792416
[TBL] [Abstract][Full Text] [Related]
10. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
11. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):396-402. PubMed ID: 25074472
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and the risk of giant cell arteritis: results from a prospective study.
Jakobsson K; Jacobsson L; Warrington K; Matteson EL; Liang K; Melander O; Turesson C
Rheumatology (Oxford); 2015 Mar; 54(3):433-40. PubMed ID: 25193806
[TBL] [Abstract][Full Text] [Related]
14. Statin use in giant cell arteritis: a retrospective study.
Schmidt J; Kermani TA; Muratore F; Crowson CS; Matteson EL; Warrington KJ
J Rheumatol; 2013 Jun; 40(6):910-5. PubMed ID: 23547221
[TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
16. Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden.
Stamatis P; Turkiewicz A; Englund M; Jönsson G; Nilsson JÅ; Turesson C; Mohammad AJ
J Rheumatol; 2021 Feb; 48(2):251-257. PubMed ID: 32414956
[TBL] [Abstract][Full Text] [Related]
17. Malignancies in Giant Cell Arteritis: A Population-based Cohort Study.
Stamatis P; Turesson C; Willim M; Nilsson JÅ; Englund M; Mohammad AJ
J Rheumatol; 2020 Mar; 47(3):400-406. PubMed ID: 31154410
[TBL] [Abstract][Full Text] [Related]
18. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
Lo Gullo A; Koster MJ; Crowson CS; Makol A; Ytterberg SR; Saitta A; Salvarani C; Matteson EL; Warrington KJ
PLoS One; 2016; 11(2):e0149579. PubMed ID: 26901431
[TBL] [Abstract][Full Text] [Related]
19. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.
Ninan J; Nguyen AM; Cole A; Rischmueller M; Dodd T; Roberts-Thomson P; Hill CL
J Rheumatol; 2011 Oct; 38(10):2215-7. PubMed ID: 21844141
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.
González-Gay MA; Garcia-Porrua C; Rivas MJ; Rodriguez-Ledo P; Llorca J
Ann Rheum Dis; 2001 Apr; 60(4):367-71. PubMed ID: 11247867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]